Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marty H Porter

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Diabetes Technology & Therapeutics|June 25, 2002
Oxidative phosphorylation: key to lifeMarty H Porter, Carolyn D Berdanier
The Journal of Laboratory and Clinical Medicine|April 11, 2002
Effects of TNF-alpha on glucose metabolism and lipolysis in adipose tissue and isolated fat-cell preparationsMarty H Porter, Alexis Cutchins, Jacqueline B Fine, et al.
Molecular Genetics and Metabolism|August 5, 2019
Perspectives on urea cycle disorder management: Results of a clinician surveyGregory M Enns, Marty H Porter, Megan Francis-Sedlak, et al.
Obesity Research|January 27, 2004
Sexual dimorphism in the response of adipose mass and cellularity to graded caloric restrictionMarty H Porter, Jacqueline B Fine, Alexis G Cutchins, et al.
Human Gene Therapy|October 28, 2003
Glucose-responsive hepatic insulin gene therapy of spontaneously diabetic BB/Wor ratsDarin E Olson, Sara A Paveglio, Patricia U Huey, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|June 25, 2005
Host cells reduce glucose uptake and glycogen deposition in response to hepatic insulin gene therapyMarty H Porter, Sara A Paveglio, Jin-an Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2008
Hepatic insulin gene therapy normalizes diurnal fluctuation of oxidative metabolism in diabetic BB/Wor ratsDarin E Olson, Adam G Campbell, Marty H Porter, et al.
Obesity (Silver Spring, Md.)|October 31, 2009
Relationships of obesity and fat distribution with atherothrombotic risk factors: baseline results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trialJeanine B Albu, Jiang Lu, Arshag D Mooradian, et al.
Molecular Genetics and Metabolism|January 3, 2021
Glycerol phenylbutyrate efficacy and safety from an open label study in pediatric patients under 2 months of age with urea cycle disordersNicola Longo, George A Diaz, Uta Lichter-Konecki, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Diabetes Technology & Therapeutics|June 25, 2002
Oxidative phosphorylation: key to lifeMarty H Porter, Carolyn D Berdanier
The Journal of Laboratory and Clinical Medicine|April 11, 2002
Effects of TNF-alpha on glucose metabolism and lipolysis in adipose tissue and isolated fat-cell preparationsMarty H Porter, Alexis Cutchins, Jacqueline B Fine, et al.
Molecular Genetics and Metabolism|August 5, 2019
Perspectives on urea cycle disorder management: Results of a clinician surveyGregory M Enns, Marty H Porter, Megan Francis-Sedlak, et al.
Obesity Research|January 27, 2004
Sexual dimorphism in the response of adipose mass and cellularity to graded caloric restrictionMarty H Porter, Jacqueline B Fine, Alexis G Cutchins, et al.
Human Gene Therapy|October 28, 2003
Glucose-responsive hepatic insulin gene therapy of spontaneously diabetic BB/Wor ratsDarin E Olson, Sara A Paveglio, Patricia U Huey, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|June 25, 2005
Host cells reduce glucose uptake and glycogen deposition in response to hepatic insulin gene therapyMarty H Porter, Sara A Paveglio, Jin-an Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2008
Hepatic insulin gene therapy normalizes diurnal fluctuation of oxidative metabolism in diabetic BB/Wor ratsDarin E Olson, Adam G Campbell, Marty H Porter, et al.
Obesity (Silver Spring, Md.)|October 31, 2009
Relationships of obesity and fat distribution with atherothrombotic risk factors: baseline results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trialJeanine B Albu, Jiang Lu, Arshag D Mooradian, et al.
Molecular Genetics and Metabolism|January 3, 2021
Glycerol phenylbutyrate efficacy and safety from an open label study in pediatric patients under 2 months of age with urea cycle disordersNicola Longo, George A Diaz, Uta Lichter-Konecki, et al.
Pageof 1